# APADAZ
> **NDA208653** · New Drug Application · Sponsor: ZEVRA THERAP · Approved 2018-02-23
## Drug
- **FDA Application Number:** NDA208653
- **Application type:** New Drug Application
- **Brand name:** APADAZ
- **Generic name:** BENZHYDROCODONE AND ACETAMINOPHEN
- **Active ingredients:** ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ZEVRA THERAP
- **Manufacturer:** Zevra Therapeutics, Inc.
- **First approval:** 2018-02-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208653)
---
*AI Analytics · CC0 1.0*